377 related articles for article (PubMed ID: 23473685)
1. Physics controversies in proton therapy.
Engelsman M; Schwarz M; Dong L
Semin Radiat Oncol; 2013 Apr; 23(2):88-96. PubMed ID: 23473685
[TBL] [Abstract][Full Text] [Related]
2. Clinical controversies: proton therapy for thoracic tumors.
De Ruysscher D; Chang JY
Semin Radiat Oncol; 2013 Apr; 23(2):115-9. PubMed ID: 23473688
[TBL] [Abstract][Full Text] [Related]
3. Clinical controversies: proton radiation therapy for brain and skull base tumors.
Combs SE; Laperriere N; Brada M
Semin Radiat Oncol; 2013 Apr; 23(2):120-6. PubMed ID: 23473689
[TBL] [Abstract][Full Text] [Related]
4. Controversies in clinical trials in proton radiotherapy: the present and the future.
Miller RC; Lodge M; Murad MH; Jones B
Semin Radiat Oncol; 2013 Apr; 23(2):127-33. PubMed ID: 23473690
[TBL] [Abstract][Full Text] [Related]
5. Clinical controversies: proton therapy for pediatric tumors.
Merchant TE
Semin Radiat Oncol; 2013 Apr; 23(2):97-108. PubMed ID: 23473686
[TBL] [Abstract][Full Text] [Related]
6. Clinical controversies: proton therapy for prostate cancer.
Mouw KW; Trofimov A; Zietman AL; Efstathiou JA
Semin Radiat Oncol; 2013 Apr; 23(2):109-14. PubMed ID: 23473687
[TBL] [Abstract][Full Text] [Related]
7. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
8. Protons vs Photons for Brain and Skull Base Tumors.
Ahmed SK; Brown PD; Foote RL
Semin Radiat Oncol; 2018 Apr; 28(2):97-107. PubMed ID: 29735196
[TBL] [Abstract][Full Text] [Related]
9. Advancing (proton) radiation therapy.
Paganetti H
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):871-3. PubMed ID: 24267966
[No Abstract] [Full Text] [Related]
10. Place of proton radiotherapy in future radiotherapy practice.
Zips D; Baumann M
Semin Radiat Oncol; 2013 Apr; 23(2):149-53. PubMed ID: 23473693
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric comparison between proton and photon beams in the moving gap region in cranio-spinal irradiation (CSI).
Cheng CW; Das IJ; Srivastava SP; Zhao L; Wolanski M; Simmons J; Johnstone PA; Buchsbaum JC
Acta Oncol; 2013 Apr; 52(3):553-60. PubMed ID: 22554342
[TBL] [Abstract][Full Text] [Related]
12. Biological considerations when comparing proton therapy with photon therapy.
Paganetti H; van Luijk P
Semin Radiat Oncol; 2013 Apr; 23(2):77-87. PubMed ID: 23473684
[TBL] [Abstract][Full Text] [Related]
13. Clinical Trial Strategies to Compare Protons With Photons.
Langendijk JA; Boersma LJ; Rasch CRN; van Vulpen M; Reitsma JB; van der Schaaf A; Schuit E
Semin Radiat Oncol; 2018 Apr; 28(2):79-87. PubMed ID: 29735194
[TBL] [Abstract][Full Text] [Related]
14. Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care.
Kamran SC; Light JO; Efstathiou JA
Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):509-521. PubMed ID: 30967625
[TBL] [Abstract][Full Text] [Related]
15. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field.
Paganetti H; Athar BS; Moteabbed M; A Adams J; Schneider U; Yock TI
Phys Med Biol; 2012 Oct; 57(19):6047-61. PubMed ID: 22968191
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy.
Fogliata A; Scorsetti M; Navarria P; Catalano M; Clivio A; Cozzi L; Lobefalo F; Nicolini G; Palumbo V; Pellegrini C; Reggiori G; Roggio A; Vanetti E; Alongi F; Pentimalli S; Mancosu P
Acta Oncol; 2013 Apr; 52(3):545-52. PubMed ID: 22671576
[TBL] [Abstract][Full Text] [Related]
18. Normal tissue complications from low-dose proton therapy.
Mahajan A
Health Phys; 2012 Nov; 103(5):586-9. PubMed ID: 23032888
[TBL] [Abstract][Full Text] [Related]
19. Incorporating a compact proton therapy unit into an existing National Cancer Institute-designated comprehensive cancer center.
Mansur DB
Expert Rev Anticancer Ther; 2014 Sep; 14(9):1001-5. PubMed ID: 25109233
[TBL] [Abstract][Full Text] [Related]
20. Quantitative metrics for assessing plan quality.
Moore KL; Brame RS; Low DA; Mutic S
Semin Radiat Oncol; 2012 Jan; 22(1):62-9. PubMed ID: 22177879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
